MedPath

ORAL-B ANTI-CAVITY DENTAL RINSE .05%

ORAL-B ANTI-CAVITY DENTAL RINSE .05%

Discontinued
DIN Number

02050382

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

oral-b laboratories, a div. of procter & gamble inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02050382
AIG Number0107147014
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A01AA01 SODIUM FLUORIDE
Product Specifications
Dosage FormLiquid
Route of AdministrationBuccal ,  Topical
AHFS Classification34:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SODIUM FLUORIDEActive
Strength: 0.05 %
Monograph: SODIUM FLUORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.